MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Organogenesis Holdings P/CF Ratio 2011-2026 | ORGO
Annual P/CF Ratio Organogenesis Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32.7 | 29.2 | 15.4 | 12 | 19.1 | 148 | -11 | -15.1 | -158 | -139 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 148 | -158 | -13.2 |
P/CF Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cumberland Pharmaceuticals
CPIX
|
17.2 | $ 6.29 | 7.07 % | $ 93.4 M |  USA |
 |
Endo International plc
ENDP
|
0.157 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-0.0374 | - | - | $ 36.6 M | USA |
 |
HEXO Corp.
HEXO
|
-2.36 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-2.17 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-1.75 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-0.923 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.694 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-3.28 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-0.135 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-7.12 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
28.5 | $ 2.75 | 0.18 % | $ 1.05 B | Canada |
 |
Athenex
ATNX
|
-8.43 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
44.1 | $ 33.59 | 1.79 % | $ 1.23 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-15.3 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
40.5 | - | - | $ 11.5 B | USA |
 |
Pacira BioSciences
PCRX
|
6.22 | $ 24.14 | 3.38 % | $ 1.12 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
6.7 | - | -39.89 % | $ 27.7 M | USA |
 |
Bausch Health Companies
BHC
|
1.45 | $ 5.43 | -0.82 % | $ 2.01 B | Canada |
 |
Canopy Growth Corporation
CGC
|
-0.857 | $ 1.05 | 1.1 % | $ 113 M | Canada |
 |
Solid Biosciences
SLDB
|
-3.99 | $ 6.8 | 2.64 % | $ 595 M | USA |
 |
Aurora Cannabis
ACB
|
14 | $ 3.47 | 0.14 % | $ 190 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-41.6 | $ 1.08 | -2.27 % | $ 1.34 M | USA |
 |
Jupiter Wellness
JUPW
|
-1.59 | - | - | $ 33.6 M | USA |
 |
Tilray
TLRY
|
151 | $ 5.42 | 2.46 % | $ 3.35 B | Canada |
 |
Lannett Company
LCI
|
0.647 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
38.9 | $ 1.12 | - | $ 107 M | Canada |
 |
Evolus
EOLS
|
-6.42 | $ 6.2 | 1.72 % | $ 400 M | USA |
 |
Sundial Growers
SNDL
|
-0.00572 | $ 1.44 | -0.68 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
2.65 | $ 9.06 | 7.22 % | $ 485 M | USA |
 |
Veru
VERU
|
-2.83 | $ 2.3 | -2.17 % | $ 33.7 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-0.0334 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
-2.67 | $ 23.45 | 0.04 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
4.57 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-17.5 | - | - | $ 1.42 B | USA |
 |
cbdMD
YCBD
|
-2.47 | $ 0.74 | -2.6 % | $ 2.98 M | USA |
 |
PetIQ
PETQ
|
6.4 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-5.39 | $ 7.03 | -0.21 % | $ 278 M | USA |
 |
Recro Pharma
REPH
|
-133 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-9.33 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-7.18 | $ 0.7 | -4.33 % | $ 35 M | USA |
 |
PLx Pharma
PLXP
|
-3.72 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
6.34 | $ 16.29 | -2.19 % | $ 19 B | USA |
 |
Zomedica Corp.
ZOM
|
-8.59 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.815 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-51.3 | $ 0.75 | -5.4 % | $ 27 M | USA |
 |
Tricida
TCDA
|
-2.91 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
18.5 | $ 0.76 | 0.05 % | $ 3.26 M |  China |
 |
TherapeuticsMD
TXMD
|
-2.79 | $ 2.1 | -1.16 % | $ 24.3 M | USA |